Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stromal Cell Derivatives: a New Alternative and Potential Product for the Treatment of Diabetic Foot Ulcers 1 and 2

NCT02943486 is registered in ClinicalTrials.gov with Universidad Autónoma de Bucaramanga as lead sponsor.

NCT NCT02943486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02943486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stromal Cell Derivatives: a New Alternative and Potential Product for the Treatment of Diabetic Foot Ulcers 1 and 2
Lead sponsor
Universidad Autónoma de Bucaramanga
Phase
Phase 1/2
Overall status
Unknown status
Start date
January 31, 2017
Completion date
January 31, 2019
Enrollment
51 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

foot ulcer, diabetic